Bari Kowal serves as Regeneron’s Senior Vice President of Development Operations, Portfolio Management and Biostatistics Data Management, where she is responsible for leading the execution and strategy of approximately 160 global clinical trials for Regeneron’s robust pipeline that spans multiple focus areas, from genetic medicines to oncology, ophthalmology, to rare disease. She was previously at Pfizer, where she held the positions of Vice President, Business Operations and Analytics and Vice President, Strategic Alliance and Development Operations Lead. Ms. Kowal also served as Vice President, Clinic...read more